Related Experiment Video
Updated: Jul 20, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
HFE mutations and risk of coronary heart disease in middle-aged women
D L van der A1, P H M Peeters, D E Grobbee
1University Medical Center Utrecht, the Netherlands.
Insights
HFE gene mutations, including C282Y and H63D, do not appear to increase the risk of coronary heart disease (CHD) in middle-aged women. This study found no significant association between HFE carriership and CHD development.
Area of Science:
- Genetics and Cardiovascular Health
- Human Molecular Genetics
- Epidemiology of Chronic Diseases
Background:
- Heterozygosity for HFE gene mutations (C282Y) is linked to cardiovascular risk, but evidence is inconclusive.
- The association between HFE mutations and coronary heart disease (CHD) risk requires further investigation.
- This study focuses on middle-aged women to clarify the role of HFE mutations in CHD risk.
Purpose of the Study:
- To investigate the association between HFE gene mutations (C282Y and H63D) and the risk of coronary heart disease (CHD).
- To provide further evidence on whether HFE mutation carriers are at increased risk of CHD.
- To analyze data from a large cohort of Dutch middle-aged women.
Main Methods:
- A cohort of 15,236 Dutch middle-aged women was studied.
- HFE genotyping was performed on 211 CHD cases and 1526 controls.
- Weighted Cox proportional hazards models were used to estimate hazard ratios for C282Y and H63D carriership.
Main Results:
- Carriers of the C282Y allele showed no increased risk for CHD (HR = 1.25, 95% CI = 0.74-2.09).
- No association was found between the H63D mutation and CHD risk (HR = 0.73, 95% CI = 0.43-1.24).
- Results were adjusted for age and other potential confounders.
Conclusions:
- HFE mutations (C282Y and H63D) do not appear to influence the risk of coronary heart disease.
- Findings align with existing literature, supported by an included meta-analysis.
- The study suggests HFE genotype is not a significant risk factor for CHD in this population.
Background:
Although heterozygosity for the C282Y mutation in the HFE gene has been associated with an increased risk of cardiovascular events, epidemiological studies remain inconclusive. The aim of the present study was to obtain further evidence as to whether HFE mutations are associated with risk of coronary heart disease (CHD) in middle-aged women. We used data of a cohort of 15 236 Dutch middle-aged women to investigate whether C282Y carriers and H63D carriers are at increased risk of coronary heart disease compared with non-carriers.
Materials And Methods:
Women were included in the study between 1993 and 1997 and were followed until 1 January 2000 for cardiovascular events. HFE genotyping was performed on all 211 coronary heart disease cases and a randomly selected sample from the baseline cohort (n = 1526). A weighted Cox proportional hazards model was used to estimate crude, age-adjusted and multivariate adjusted hazard ratios for C282Y and H63D carriership in relation to coronary heart disease.
Results:
Compared with non-carriers, those that carried the C282Y allele were not at increased risk for CHD (HR = 1.25, 95% CI = 0.74-2.09). Neither did we find an association between the H63D mutation and CHD risk (HR = 0.73, 95% CI = 0.43-1.24).
Conclusions:
Our results are in accordance with similar studies to date, for which we present a meta-analysis. HFE mutations appear not to affect the risk of coronary heart disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
